<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00997555</url>
  </required_header>
  <id_info>
    <org_study_id>HMC0001</org_study_id>
    <nct_id>NCT00997555</nct_id>
  </id_info>
  <brief_title>Prophylactic Bronchoscopy After Inhalation Injury in Burn Patients</brief_title>
  <official_title>Prophylactic Bronchoscopy After Inhalation Injury in Burn Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hurley Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hurley Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators hypothesize that the scheduled use of bronchoscopy on a regular basis after
      inhalation injury in burn patients will improve outcome by providing pulmonary hygiene,
      decrease the incidence of pneumonia, and detect pneumonia earlier than standard treatment
      without bronchoscopy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The role of bronchoscopy in most hospitals has been limited to obtaining lavage fluid for
      culture and assessing the degree of airway injury, which has been shown to be predictive of
      outcome. Severe inhalation injury, which is characterized by pulmonary edema, bronchial
      edema, and secretions, can occlude the airway and lead to atelectasis and pneumonia.
      Aggressive use of bronchoscopy is highly effective in removing foreign particles and
      accumulated secretions that worsen the inflammatory response and impede ventilation. While it
      seems intuitive that bronchoscopy would improve pulmonary hygiene by removing secretions and
      denuded epithelial slough in burn patients, there has not been any published data to support
      or deter the use of bronchoscopy for inhalation injury nor document an improvement in
      morbidity or mortality secondary to bronchoscopy as a therapeutic intervention.

      Recent research has shown that the process of intubation for mechanical ventilation provides
      a portal for bacterial contamination, after which the damaged tracheobronchial mucosa quickly
      becomes colonized with pathogenic organisms in over 50% of the patients. Furthermore, within
      15 minutes of smoke inhalation, there is significant airway edema and thickening, more
      prominently in the lower trachea than the upper portion. These factors place the patient with
      inhalation injury at high risk for pneumonia.

      We have used the National Burn Repository data to previously show that patients who receive
      aggressive use of bronchoscopy after inhalation injury have an improved outcome in terms of
      decreased ventilator days, decreased ICU length of stay, decreased incidence of pneumonia,
      and a trend towards improved mortality. However, that data was unable to document why. It was
      also unable to confirm that the findings were not due to institutional bias. Therefore, one
      of the conclusions from that study was that a prospective trial is needed to confirm the
      findings.

      Our hypothesis is that a scheduled and sequential use of bronchoscopy after inhalation injury
      as a therapeutic tool to remove secretions, slough, carbonaceous material, and screen for the
      early detection of pneumonia by bronchoalveolar lavage (BAL) will improve outcome. We will
      attempt to document this improvement by using the following endpoints: length of ICU stay,
      length of hospital stay, ventilator days, incidence of pneumonia, overall morbidity and
      mortality with and without bronchoscopy.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2009</start_date>
  <completion_date type="Actual">July 2012</completion_date>
  <primary_completion_date type="Actual">July 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>All Cause Mortality</measure>
    <time_frame>until death or discharge from hospital, data reviewed every 6 months</time_frame>
    <description>Bronchoscopy group deaths n=0. Control group deaths n=1.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Respiratory Associated Mortality</measure>
    <time_frame>until death or discharge from hospital, data reviewed every 6 months</time_frame>
    <description>Bronchoscopy group deaths n=0. Control group deaths n=1.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Incidence of Pneumonia</measure>
    <time_frame>until discharge from the hospital, data reviewed every 6 months</time_frame>
    <description>Bronchoscopy group- 4/13 (31%) Control group- 6/15 (40%)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of Mechanical Ventilation</measure>
    <time_frame>until discharge from hospital, data reviewed every 6 months</time_frame>
    <description>Days of mechanical ventilation (bronchoscopy 5.1 days, 95% CI +/- 3.6 days versus control 6.7 days, 95% CI +/- 6.3 days, p = 0.7).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of ICU Stay</measure>
    <time_frame>until discharge from hospital, data reviewed every 6 months</time_frame>
    <description>Number of ICU days (bronchoscopy 10 days, 95% CI +/- 10 days versus control 18 days, 95% CI +/- 12 days, p = 0.4).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of Hospital Stay</measure>
    <time_frame>until discharge from hospital, data reviewed every 6 months</time_frame>
    <description>Number of hospital days (bronchoscopy 21 days, 95% CI +/- 12 days versus control 26 days, 95% CI +/- 12 days, p = 0.5).</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">28</enrollment>
  <condition>Inhalation Injury</condition>
  <condition>Pneumonitis</condition>
  <condition>Pneumonia</condition>
  <arm_group>
    <arm_group_label>bronchoscopy intervention group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Group undergoing scheduled bronchoscopy.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Standard treatment without scheduled bronchoscopy.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>bronchoscopy</intervention_name>
    <description>Scheduled bronchoscopy.</description>
    <arm_group_label>bronchoscopy intervention group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Any burned patient arriving intubated on mechanical ventilation OR requiring
             mechanical ventilation within 48 hours of admission AND

          2. &gt; 18 years old AND

          3. patient believed to be able to survive more than 48 hours after arrival (not likely to
             be made DNR or comfort care) including:

               -  any methamphetamine explosion or

               -  any burn associated with fire (not chemical) of the face or blast injury to the
                  face or

               -  confined in a burning space for more than 10 minutes or

               -  any burn with carbonaceous material around the nose or mouth or

               -  any burn &gt; 15% TBSA associated with fire (not chemical) or

               -  any burn associated with an explosion in a confined space.

        Exclusion Criteria:

          1. Likely to die within 48 hours based upon severity of injury.

          2. Less than 18 years old.

          3. Burned patient transferred to our facility already on mechanical ventilation for more
             than 48 hours.

          4. Patient already on antibiotics for another reason.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>John A Carr, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hurley Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hurley Medical Center</name>
      <address>
        <city>Flint</city>
        <state>Michigan</state>
        <zip>48503</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 15, 2009</study_first_submitted>
  <study_first_submitted_qc>October 16, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 19, 2009</study_first_posted>
  <results_first_submitted>September 4, 2012</results_first_submitted>
  <results_first_submitted_qc>December 22, 2012</results_first_submitted_qc>
  <results_first_posted type="Estimate">January 31, 2013</results_first_posted>
  <last_update_submitted>December 22, 2012</last_update_submitted>
  <last_update_submitted_qc>December 22, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 31, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>inhalation</keyword>
  <keyword>bronchoscopy</keyword>
  <keyword>burn</keyword>
  <keyword>pneumonia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Wounds and Injuries</mesh_term>
    <mesh_term>Pneumonia</mesh_term>
    <mesh_term>Respiratory Aspiration</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>From 2009-2012, 33 patients with inhalation injury were admitted to our regional burn center.</recruitment_details>
      <pre_assignment_details>Five were never enrolled. Two patientâ€™s families refused to consent, and two fell into exclusion criteria number 1. Both died within six hours of admission. The remaining fifth patient self-extubated and thus failed to meet inclusion criteria number 1. This left 28 patients for analysis, all of whom were enrolled and randomized into the study.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Bronchoscopy Intervention Group</title>
          <description>Group undergoing scheduled bronchoscopy. Patients had bronchoscopy and BAL performed within 12 hours of arrival and every 3 days sequentially. A positive BAL (&gt; 100K CFU/ml) were treated with antibiotics according to sensitivites.</description>
        </group>
        <group group_id="P2">
          <title>Control Group</title>
          <description>Standard treatment without scheduled bronchoscopy.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="13"/>
                <participants group_id="P2" count="15"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="13"/>
                <participants group_id="P2" count="15"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Bronchoscopy Intervention Group</title>
          <description>Group undergoing scheduled bronchoscopy. Patients had bronchoscopy and BAL performed within 12 hours of arrival and every 3 days sequentially. A positive BAL (&gt; 100K CFU/ml) were treated with antibiotics according to sensitivites.</description>
        </group>
        <group group_id="B2">
          <title>Control Group</title>
          <description>Standard treatment without scheduled bronchoscopy.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="13"/>
            <count group_id="B2" value="15"/>
            <count group_id="B3" value="28"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="15"/>
                    <measurement group_id="B3" value="23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="51" spread="11"/>
                    <measurement group_id="B2" value="35" spread="8"/>
                    <measurement group_id="B3" value="42" spread="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="11"/>
                    <measurement group_id="B2" value="12"/>
                    <measurement group_id="B3" value="23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="13"/>
                    <measurement group_id="B2" value="15"/>
                    <measurement group_id="B3" value="28"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>All Cause Mortality</title>
        <description>Bronchoscopy group deaths n=0. Control group deaths n=1.</description>
        <time_frame>until death or discharge from hospital, data reviewed every 6 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Bronchoscopy Intervention Group</title>
            <description>Group undergoing scheduled bronchoscopy. Patients had bronchoscopy and BAL performed within 12 hours of arrival and every 3 days sequentially. A positive BAL (&gt; 100K CFU/ml) were treated with antibiotics according to sensitivites.</description>
          </group>
          <group group_id="O2">
            <title>Control Group</title>
            <description>Standard treatment without scheduled bronchoscopy.</description>
          </group>
        </group_list>
        <measure>
          <title>All Cause Mortality</title>
          <description>Bronchoscopy group deaths n=0. Control group deaths n=1.</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="13"/>
                <count group_id="O2" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Respiratory Associated Mortality</title>
        <description>Bronchoscopy group deaths n=0. Control group deaths n=1.</description>
        <time_frame>until death or discharge from hospital, data reviewed every 6 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Bronchoscopy Intervention Group</title>
            <description>Group undergoing scheduled bronchoscopy. Patients had bronchoscopy and BAL performed within 12 hours of arrival and every 3 days sequentially. A positive BAL (&gt; 100K CFU/ml) were treated with antibiotics according to sensitivites.</description>
          </group>
          <group group_id="O2">
            <title>Control Group</title>
            <description>Standard treatment without scheduled bronchoscopy.</description>
          </group>
        </group_list>
        <measure>
          <title>Respiratory Associated Mortality</title>
          <description>Bronchoscopy group deaths n=0. Control group deaths n=1.</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="13"/>
                <count group_id="O2" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Incidence of Pneumonia</title>
        <description>Bronchoscopy group- 4/13 (31%) Control group- 6/15 (40%)</description>
        <time_frame>until discharge from the hospital, data reviewed every 6 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Bronchoscopy Intervention Group</title>
            <description>Group undergoing scheduled bronchoscopy. Patients had bronchoscopy and BAL performed within 12 hours of arrival and every 3 days sequentially. A positive BAL (&gt; 100K CFU/ml) were treated with antibiotics according to sensitivites.</description>
          </group>
          <group group_id="O2">
            <title>Control Group</title>
            <description>Standard treatment without scheduled bronchoscopy.</description>
          </group>
        </group_list>
        <measure>
          <title>Incidence of Pneumonia</title>
          <description>Bronchoscopy group- 4/13 (31%) Control group- 6/15 (40%)</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="13"/>
                <count group_id="O2" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                    <measurement group_id="O2" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.6</p_value>
            <method>Chi-squared</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Length of Mechanical Ventilation</title>
        <description>Days of mechanical ventilation (bronchoscopy 5.1 days, 95% CI +/- 3.6 days versus control 6.7 days, 95% CI +/- 6.3 days, p = 0.7).</description>
        <time_frame>until discharge from hospital, data reviewed every 6 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Bronchoscopy Intervention Group</title>
            <description>Group undergoing scheduled bronchoscopy. Patients had bronchoscopy and BAL performed within 12 hours of arrival and every 3 days sequentially. A positive BAL (&gt; 100K CFU/ml) were treated with antibiotics according to sensitivites.</description>
          </group>
          <group group_id="O2">
            <title>Control Group</title>
            <description>Standard treatment without scheduled bronchoscopy.</description>
          </group>
        </group_list>
        <measure>
          <title>Length of Mechanical Ventilation</title>
          <description>Days of mechanical ventilation (bronchoscopy 5.1 days, 95% CI +/- 3.6 days versus control 6.7 days, 95% CI +/- 6.3 days, p = 0.7).</description>
          <units>days</units>
          <param>Median</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="13"/>
                <count group_id="O2" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.1" lower_limit="2.5" upper_limit="8.7"/>
                    <measurement group_id="O2" value="6.7" lower_limit="0.4" upper_limit="13.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.7</p_value>
            <p_value_desc>(bronchoscopy 5.1 days, 95% CI +/- 3.6 days versus control 6.7 days, 95% CI +/- 6.3 days, p = 0.7).</p_value_desc>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Length of ICU Stay</title>
        <description>Number of ICU days (bronchoscopy 10 days, 95% CI +/- 10 days versus control 18 days, 95% CI +/- 12 days, p = 0.4).</description>
        <time_frame>until discharge from hospital, data reviewed every 6 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Bronchoscopy Intervention Group</title>
            <description>Group undergoing scheduled bronchoscopy. Patients had bronchoscopy and BAL performed within 12 hours of arrival and every 3 days sequentially. A positive BAL (&gt; 100K CFU/ml) were treated with antibiotics according to sensitivites.</description>
          </group>
          <group group_id="O2">
            <title>Control Group</title>
            <description>Standard treatment without scheduled bronchoscopy.</description>
          </group>
        </group_list>
        <measure>
          <title>Length of ICU Stay</title>
          <description>Number of ICU days (bronchoscopy 10 days, 95% CI +/- 10 days versus control 18 days, 95% CI +/- 12 days, p = 0.4).</description>
          <units>days</units>
          <param>Median</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="13"/>
                <count group_id="O2" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10" lower_limit="0" upper_limit="20"/>
                    <measurement group_id="O2" value="18" lower_limit="6" upper_limit="30"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.4</p_value>
            <method>t-test, 2 sided</method>
            <method_desc>(bronchoscopy 10 days, 95% CI +/- 10 days versus control 18 days, 95% CI +/- 12 days, p = 0.4).</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Length of Hospital Stay</title>
        <description>Number of hospital days (bronchoscopy 21 days, 95% CI +/- 12 days versus control 26 days, 95% CI +/- 12 days, p = 0.5).</description>
        <time_frame>until discharge from hospital, data reviewed every 6 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Bronchoscopy Intervention Group</title>
            <description>Group undergoing scheduled bronchoscopy. Patients had bronchoscopy and BAL performed within 12 hours of arrival and every 3 days sequentially. A positive BAL (&gt; 100K CFU/ml) were treated with antibiotics according to sensitivites.</description>
          </group>
          <group group_id="O2">
            <title>Control Group</title>
            <description>Standard treatment without scheduled bronchoscopy.</description>
          </group>
        </group_list>
        <measure>
          <title>Length of Hospital Stay</title>
          <description>Number of hospital days (bronchoscopy 21 days, 95% CI +/- 12 days versus control 26 days, 95% CI +/- 12 days, p = 0.5).</description>
          <units>days</units>
          <param>Median</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="13"/>
                <count group_id="O2" value="15"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="21" lower_limit="9" upper_limit="33"/>
                    <measurement group_id="O2" value="26" lower_limit="14" upper_limit="38"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.5</p_value>
            <method>t-test, 2 sided</method>
            <method_desc>(bronchoscopy 21 days, 95% CI +/- 12 days versus control 26 days, 95% CI +/- 12 days, p = 0.5).</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Bronchoscopy Intervention Group</title>
          <description>Group undergoing scheduled bronchoscopy. Patients had bronchoscopy and BAL performed within 12 hours of arrival and every 3 days sequentially. A positive BAL (&gt; 100K CFU/ml) were treated with antibiotics according to sensitivites.</description>
        </group>
        <group group_id="E2">
          <title>Control Group</title>
          <description>Standard treatment without scheduled bronchoscopy.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="15"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="15"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>John Alfred Carr, MD</name_or_title>
      <organization>Hurley Medical Center</organization>
      <phone>810-262-4993</phone>
      <email>heartandbones@yahoo.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

